David Michael Ott
24Patents
8h-index
13Co-inventors
72Inventor score
Filing activity: Jul 30, 1976 → Aug 29, 2019
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US4041456A | Method for verifying the denomination of currency | Physics | 217 | Expired |
| US5600732A | Document image analysis method | Physics | 192 | Expired |
| US5754674A | Document image analysis method | Physics | 75 | Expired |
| US4853970A | Apparatus for processing digitized images | Physics | 55 | Expired |
| US4827330A | Automatic document image revision | Electricity | 51 | Expired |
| US7678833B2 | Method to increase the bioavailability of cysteine | Human Necessities | 27 | Active |
| US5020122A | Automatic document image revision | Electricity | 18 | Expired |
| US8217084B2 | Medicinal products incorporating bound organosulfur groups | Human Necessities | 8 | Expired |
| US8222299B2 | Organosulfur prodrugs for the prevention and treatment of infectious diseases | Human Necessities | 3 | Active |
| US11147815B2 | Compositions and methods for treating diseases associated with uncontrolled inflammatory responses | Chemistry; Metallurgy | 2 | Active |
| US11482305B2 | Artificial intelligence analysis of RNA transcriptome for drug discovery | Physics | 0 | Active |
| US10940129B2 | Method of treatment for reducing pain sensitization | Human Necessities | 0 | Active |
| US10118891B2 | Organosulfur compounds for the prevention and treatment of neurodegenerative diseases | Human Necessities | 0 | Active |
| US11396542B2 | Astrotactin1-based compositions and pharmaceutical formulations | Physics | 0 | Active |
| US9562007B2 | Organosulfur compounds for the prevention and treatment of neurodegenerative diseases | Human Necessities | 0 | Active |
| US9456999B2 | Organosulfur compounds for the prevention and treatment of neurodegenerative diseases | Human Necessities | 0 | Active |
| US9968580B2 | Method of treating Rett syndrome by oral administration of acetate which is provided as composition comprising magnesium acetate, calcium acetate or ethylacetate | Human Necessities | 0 | Active |
| US11026911B2 | Method of dietary treatment for genetic and epigenetic diseases and disorders | Human Necessities | 0 | Active |
| US10919955B2 | Rodent combinatorial antibody libraries | Chemistry; Metallurgy | 0 | Active |
| US10258581B2 | Organosulfur compounds for the prevention and treatment of neurodegenerative diseases | Human Necessities | 0 | Active |
| US10758498B2 | Method of decreasing protein-aldehyde adducts by administering a mixed disulfide of n-acetylcysteine and propyl mercaptan, propenyl mercaptan, or allyl mercaptan | Human Necessities | 0 | Active |
| US9226885B2 | Personal care and medicinal products incorporating bound organosulfur groups | Human Necessities | 0 | Active |
| US9650432B2 | Rodent combinatorial antibody libraries | Chemistry; Metallurgy | 0 | Active |
| US10583106B2 | Method of treating cancer by oral administration of acetate composition comprising magnesium acetate, calcium acetate or ethylacetate | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.